Though previous studies suggest that hypermethylation in binding sites of insulator proteins may activate PDGFRA expression and thereby generate a proliferative advantage in IDH-mutant gliomas [72], the exact developmental pathways affected by IDH mutation-induced global DNA hypermethylation in gliomas are hitherto unclear. The gene discussed is PDGFRA; the disease is central nervous system cancer.